Literature DB >> 23871230

A decade of reversal: an analysis of 146 contradicted medical practices.

Vinay Prasad1, Andrae Vandross, Caitlin Toomey, Michael Cheung, Jason Rho, Steven Quinn, Satish Jacob Chacko, Durga Borkar, Victor Gall, Senthil Selvaraj, Nancy Ho, Adam Cifu.   

Abstract

OBJECTIVE: To identify medical practices that offer no net benefits.
METHODS: We reviewed all original articles published in 10 years (2001-2010) in one high-impact journal. Articles were classified on the basis of whether they addressed a medical practice, whether they tested a new or existing therapy, and whether results were positive or negative. Articles were then classified as 1 of 4 types: replacement, when a new practice surpasses standard of care; back to the drawing board, when a new practice is no better than current practice; reaffirmation, when an existing practice is found to be better than a lesser standard; and reversal, when an existing practice is found to be no better than a lesser therapy. This study was conducted from August 1, 2011, through October 31, 2012.
RESULTS: We reviewed 2044 original articles, 1344 of which concerned a medical practice. Of these, 981 articles (73.0%) examined a new medical practice, whereas 363 (27.0%) tested an established practice. A total of 947 studies (70.5%) had positive findings, whereas 397 (29.5%) reached a negative conclusion. A total of 756 articles addressing a medical practice constituted replacement, 165 were back to the drawing board, 146 were medical reversals, 138 were reaffirmations, and 139 were inconclusive. Of the 363 articles testing standard of care, 146 (40.2%) reversed that practice, whereas 138 (38.0%) reaffirmed it.
CONCLUSION: The reversal of established medical practice is common and occurs across all classes of medical practice. This investigation sheds light on low-value practices and patterns of medical research. Published by Elsevier Inc.

Mesh:

Year:  2013        PMID: 23871230     DOI: 10.1016/j.mayocp.2013.05.012

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  93 in total

1.  Medical Debates and Medical Reversal.

Authors:  Adam S Cifu; Vinay K Prasad
Journal:  J Gen Intern Med       Date:  2015-12       Impact factor: 5.128

2.  [Overtreatment: Initiatives to identify ineffective and inappropriate medical interventions].

Authors:  Claudia Wild; Julia Mayer
Journal:  Wien Med Wochenschr       Date:  2016-02-16

3.  Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm.

Authors:  Laura Barrie Smith; Nihar R Desai; Bryan Dowd; Alexander Everhart; Jeph Herrin; Lucas Higuera; Molly Moore Jeffery; Anupam B Jena; Joseph S Ross; Nilay D Shah; Pinar Karaca-Mandic
Journal:  Int J Health Econ Manag       Date:  2020-04-30

4.  Is evidence-based medicine overrated in family medicine?: No.

Authors:  Michel Labrecque; Michel Cauchon
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

5.  Ups and downs of evidence and practice guidelines.

Authors:  Roger Ladouceur
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

6.  A Framework for Enhancing the Value of Research for Dissemination and Implementation.

Authors:  Gila Neta; Russell E Glasgow; Christopher R Carpenter; Jeremy M Grimshaw; Borsika A Rabin; Maria E Fernandez; Ross C Brownson
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

7.  Is research from databases reliable? Yes.

Authors:  Jean-Francois Timsit; Jerome Aboab; Jean-Jacques Parienti
Journal:  Intensive Care Med       Date:  2018-12-14       Impact factor: 17.440

8.  Treatment of newly diagnosed myeloma: Bortezomib-based triplet.

Authors:  Archana M Rajan; S Vincent Rajkumar
Journal:  Semin Oncol       Date:  2016-11-05       Impact factor: 4.929

Review 9.  The reversal of cardiology practices: interventions that were tried in vain.

Authors:  Vinay Prasad; Adam Cifu
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

10.  The potential value of discordant studies.

Authors:  Mark Doyle
Journal:  Cardiovasc Diagn Ther       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.